---
pmid: '17632056'
title: CIP2A inhibits PP2A in human malignancies.
authors:
- Junttila MR
- Puustinen P
- Niemelä M
- Ahola R
- Arnold H
- Böttzauw T
- Ala-aho R
- Nielsen C
- Ivaska J
- Taya Y
- Lu SL
- Lin S
- Chan EK
- Wang XJ
- Grènman R
- Kast J
- Kallunki T
- Sears R
- Kähäri VM
- Westermarck J
journal: Cell
year: '2007'
full_text_available: false
doi: 10.1016/j.cell.2007.04.044
---

# CIP2A inhibits PP2A in human malignancies.
**Authors:** Junttila MR, Puustinen P, Niemelä M, Ahola R, Arnold H, Böttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grènman R, Kast J, Kallunki T, Sears R, Kähäri VM, Westermarck J
**Journal:** Cell (2007)
**DOI:** [10.1016/j.cell.2007.04.044](https://doi.org/10.1016/j.cell.2007.04.044)

## Abstract

1. Cell. 2007 Jul 13;130(1):51-62. doi: 10.1016/j.cell.2007.04.044.

CIP2A inhibits PP2A in human malignancies.

Junttila MR(1), Puustinen P, Niemelä M, Ahola R, Arnold H, Böttzauw T, Ala-aho 
R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grènman R, Kast 
J, Kallunki T, Sears R, Kähäri VM, Westermarck J.

Author information:
(1)Centre for Biotechnology, University of Turku and Abo Akademi University, 
20520 Turku, Finland.

Comment in
    Cell. 2007 Jul 13;130(1):21-4. doi: 10.1016/j.cell.2007.06.034.

Inhibition of protein phosphatase 2A (PP2A) activity has been identified as a 
prerequisite for the transformation of human cells. However, the molecular 
mechanisms by which PP2A activity is inhibited in human cancers are currently 
unclear. In this study, we describe a cellular inhibitor of PP2A with oncogenic 
activity. The protein, designated Cancerous Inhibitor of PP2A (CIP2A), interacts 
directly with the oncogenic transcription factor c-Myc, inhibits PP2A activity 
toward c-Myc serine 62 (S62), and thereby prevents c-Myc proteolytic 
degradation. In addition to its function in c-Myc stabilization, CIP2A promotes 
anchorage-independent cell growth and in vivo tumor formation. The oncogenic 
activity of CIP2A is demonstrated by transformation of human cells by 
overexpression of CIP2A. Importantly, CIP2A is overexpressed in two common human 
malignancies, head and neck squamous cell carcinoma (HNSCC) and colon cancer. 
Thus, our data show that CIP2A is a human oncoprotein that inhibits PP2A and 
stabilizes c-Myc in human malignancies.

DOI: 10.1016/j.cell.2007.04.044
PMID: 17632056 [Indexed for MEDLINE]
